Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study

Por Romain Courcelle, Stéphane Gaudry, Nicolas Serck, Gauthier Blonz, Jean-Baptiste Lascarrou, David Grimaldi, on behalf the COVADIS study group
Publicado em 2020-07-01